VRCA · Verrica Pharmaceuticals Inc. · Off Exchange
$3.56
-0.16 (-4.30%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Going-concern doubt
— flagged Nov 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on our current business plan and current capital resources, combined with the uncertainty regarding the availability of additional funding, we have concluded that there is substantial doubt regarding our ability to continue as a going concern within one year after the date these consolidated financial statements are issued.”View the 10-Q filed Nov 13, 2026
Market Cap
$61.16M
Shares
17.18M
Volume · Nov 13
18.68K
Avg daily vol (3M)
72.22K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.
Off-Exchange Volume History
| Week Start | ATS Volume | Non-ATS OTC Volume | Total Off-Exchange | % of FINRA Weekly Volume |
|---|---|---|---|---|
| 2026-10-12 | 21,501 | 158,557 | 180,058 | 48.6% |
| 2026-10-05 | 30,355 | 32,905 | 63,260 | 30.5% |
| 2026-09-28 | 19,068 | 76,987 | 96,055 | 51.1% |
| 2026-09-21 | 31,608 | 51,704 | 83,312 | 33.3% |
| 2026-09-14 | 26,054 | 104,005 | 130,059 | 44.3% |
| 2026-09-07 | 29,649 | 47,806 | 77,455 | 29.9% |
| 2026-08-31 | 21,731 | 59,210 | 80,941 | 32.6% |
| 2026-08-24 | 204,302 | 220,244 | 424,546 | 41.0% |
| 2026-08-17 | 52,375 | 129,262 | 181,637 | 29.4% |
| 2026-08-10 | 38,371 | 58,216 | 96,587 | 39.0% |
| 2026-08-03 | 24,096 | 111,043 | 135,139 | 47.5% |
| 2026-07-27 | 10,278 | 90,033 | 100,311 | 51.7% |
| 2026-07-20 | 11,740 | 17,630 | 29,370 | 32.9% |
| 2026-07-13 | 8,476 | 26,116 | 34,592 | 27.0% |
| 2026-07-06 | 21,220 | 52,182 | 73,402 | 41.8% |
| 2026-06-29 | 18,543 | 44,765 | 63,308 | 39.7% |
| 2026-06-22 | 41,253 | 139,374 | 180,627 | 53.1% |
| 2026-06-15 | 13,909 | 23,345 | 37,254 | 32.8% |
| 2026-06-08 | 29,229 | 68,623 | 97,852 | 46.4% |
| 2026-06-01 | 26,363 | 58,897 | 85,260 | 47.1% |
| 2026-05-25 | 23,637 | 42,972 | 66,609 | 50.3% |
| 2026-05-18 | 38,224 | 83,268 | 121,492 | 50.9% |
| 2026-05-11 | 90,985 | 155,980 | 246,965 | 50.2% |
| 2026-05-04 | 148,980 | 162,749 | 311,729 | 39.6% |
| 2026-04-27 | 73,556 | 94,128 | 167,684 | 55.2% |
| 2026-04-20 | 88,891 | 50,935 | 139,826 | 38.4% |
| 2026-04-13 | 149,682 | 105,498 | 255,180 | 46.7% |
| 2026-04-06 | 128,334 | 69,317 | 197,651 | 46.1% |
| 2026-03-30 | 44,187 | 63,265 | 107,452 | 35.4% |
| 2026-03-23 | 97,223 | 147,157 | 244,380 | 48.0% |
| 2026-03-16 | 123,135 | 275,864 | 398,999 | 44.9% |
| 2026-03-09 | 194,409 | 186,274 | 380,683 | 38.5% |
| 2026-03-02 | 106,462 | 122,699 | 229,161 | 41.4% |
| 2026-02-23 | 40,151 | 101,730 | 141,881 | 40.3% |
| 2026-02-16 | 262,277 | 136,052 | 398,329 | 60.0% |
| 2026-02-09 | 165,893 | 201,729 | 367,622 | 47.6% |
| 2026-02-02 | 111,023 | 222,648 | 333,671 | 38.4% |
| 2026-01-26 | 38,070 | 60,206 | 98,276 | 26.4% |
| 2026-01-19 | 159,512 | 202,197 | 361,709 | 59.7% |
| 2026-01-12 | 323,037 | 323,212 | 646,249 | 58.5% |
| 2026-01-05 | 250,328 | 160,441 | 410,769 | 49.7% |
| 2025-12-29 | 136,493 | 245,403 | 381,896 | 45.1% |
| 2025-12-22 | 82,770 | 102,652 | 185,422 | 35.0% |
| 2025-12-15 | 131,558 | 332,287 | 463,845 | 34.3% |
| 2025-12-08 | 124,349 | 253,475 | 377,824 | 43.0% |
| 2025-12-01 | 167,369 | 684,725 | 852,094 | 44.7% |
| 2025-11-24 | 272,147 | 2,365,732 | 2,637,879 | 57.0% |
| 2025-11-17 | 65,929 | 289,733 | 355,662 | 54.3% |
Showing 1–48 of 48 weeks
Key facts
CIK
1660334
CUSIP
92511W207
13F (30d)
46 filings
25 filers
Visit website
Investor relations